20th Anniversary
Membership
Current Members
Initiatives
COVID-19
Decentralized Trials
Clinical Research Roundtables
CRO Forum
Risk-Based Quality Management
Advocacy
US Legislation & Regulation
European Legislation & Regulation
Global Data Protection & Privacy
CFO Roundtable
About
ACRO Membership
Our Mission
Leadership
News
Subscribe
Facts & Figures on Clinical Research
Clinical Trial Resources for Patients
Contact Us
CRO Forum
ERT Blogpost: FDA Guidance Overview: Assessing Symptoms in Clinical Trials Aimed to Prevent and Treat COVID-19
January 6, 2021
By
Natalia Gonzalez
Previous Article
Medidata Blogpost: AI and Advanced Analytics: Delivering Value for Clinical Trials During COVID-19
Next Article
Syneos Health Factsheet: Predicting Landfall: A Dynamic Control Room for Taking on the COVID-19 Landscape